Advertisement

Photodynamic Therapy Variation in Biological Activities of HPD and Biological Effectiveness with RIF-1

  • F. A. H. Al-Watban
Part of the NATO ASI Series book series (NSSB, volume 252)

Abstract

Photobiology applied to medicine is one of the oldest interests of men. Since ancient times, human beings have had a belief in the health giving properties of sunlight and its biological effects on all life on earth. Accordingly, heliotherapy (or sun exposure) was prescribed before any modern drugs for the treatment and prevention of cutaneous tuberculosis, rickets and maintaining sterility (i.e. killing germs); further evolution is shown in Figure 1.

Keywords

High Performance Liquid Chromatography Tumor Volume Retention Interval Photodynamic Therapy Light Dose 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    T. J. Dougherty, C. J. Gomer and K. R. Weishaupt, “Energetics and efficiency of photoinactivation of murine tumor cells containing hematoporphyrin”, Cancer Res, 36:2330–2333 (1976)Google Scholar
  2. 2.
    T. J. Dougherty, D.G. Boyle and K. R. Weishaupt, “Photoradiation therapy of human tumors”, in The Science of Photomedicine, J. D. Regan, J. A. Parrish (eds), New York: Plenum Press, 625–638 (1982)Google Scholar
  3. 3.
    M. W. Berns, G. S. Berns, J. Coffey and A. G. Wile, “Exposure tables for hematoporhyrin derivative photoradiation therapy”, Lasers Surg. Med., 4:107–131 (1985)CrossRefGoogle Scholar
  4. 4.
    J. Moan, “Porphyrin photosensitization and phototherapy”, Photochem. Photobiol., 43:681–690 (1986)CrossRefGoogle Scholar
  5. 5.
    J. Moan, “Porphyrin-sensitized photodynamic inactivation of cells: A review”, Lasers Med. Sci., 1:5–12 (1986)CrossRefGoogle Scholar
  6. 6.
    B. C. Wilson and M. S. Patterson, “The physics of photodynamic therapy”, Phys. Med. Biol., 31, 4, 327–360 (1986)CrossRefGoogle Scholar
  7. 7.
    S. Chang-Ho, E. Duzman, J. Mellot, L. Liaw and M. W. Berns, “Spectroscopic, morphologic and cytotoxic studies on major fractions of hematoporhyrin derivative and photofrin II”, Lasers Surg. Med., 7:1179 (1987)Google Scholar
  8. 8.
    T. J. Dougherty, “PDT: Present and future”, Laser Med. Sci. Abstr. issue, Proceedings of the International Conference on PDT and Medical Laser Applications, London, p. 8 (1988)Google Scholar
  9. 9.
    D. R. Doiron, L. O. Svaasand and A. Profio, “Light dosimetry in tissue: Application to photoradiation therapy”, In: D. Kessel, D. J. Dougherty (eds): “Porphyrin Photosensitization”, New York: Plenum Press, 63–76. (1983)Google Scholar
  10. 10.
    L. I. Grossweiner, “Optical dosimetry in photodynamic therapy”, Lasers Surg. Med., 6:462–466 (1986)CrossRefGoogle Scholar
  11. 11.
    L. O. Svaasand, “Thermal and optical dosimetry for photoradiation therapy of malignant tumors”, in: A. Adreoni, R. Cubeddu (eds): “Porphyrin in Tumor Phototherapy”, New York: Plenum Press, 261–279 (1984)CrossRefGoogle Scholar
  12. 12.
    P. R. Twentyman, J. M. Brown, J. W. Gray, A. J. Franko, M. W. Scales and R. F. Kallman, “A new mouse tumor model system (RIF-1) for comparison of end-point studies”, JNCI, 64:595–604 (1980)Google Scholar
  13. 13.
    F. A. H. Al-Watban, G. King, R. Brannon and T. Altamero, “Photodynamic therapy: Optimal treatment parameters in murine fibrosarcoma”, Lasers Med. Sci., 2:55–62 (1987)CrossRefGoogle Scholar
  14. 14.
    F. A. H. Al-Watban, “Photodynamic therapy: Tumor volume limitation and tumor response for murine fibrosarcoma”, Lasers in Surg. Med., 10:2 (1990)Google Scholar
  15. 15.
    T. J. Dougherty, G. B. Grindey, R. Fiel, K. R. Weishaupt and D. G. Boyle, “Photoradiation therapy II. Cure of animal tumors with hematoporphyrin and light, JNCI, 55:115–121 (1975)Google Scholar
  16. 16.
    F. A. H. Al-Watban and W. R. Harrison, “Biological activity of preparation of HPD”, ICALEO Proc. Laser Res. Med., 60:75–81 (1987)Google Scholar
  17. 17.
    D. Kessel, “Tumor localization and photosensitization by derivatives of hematoporhyrin: A review”, IEEE J. Quantum Electron., WE23: 1718–1720 (1987)ADSCrossRefGoogle Scholar
  18. 18.
    T. J. Dougherty, “Photosensitizers: Therapy and detection of malignant tumors. Yearly review”, Photochem. Photobiol., 45:879–889 (1987)MathSciNetCrossRefGoogle Scholar
  19. 19.
    D. W. Marquardt, “An algorithm for least squares estimation of non-linear parameters”, J. Soc. Ind. Appl. Math., 2:431–441 (1963)MathSciNetCrossRefGoogle Scholar
  20. 20.
    B. W. Henderson, S. M. Waldow, T. S. Mong, W. R. Potter, P. B. Malone and T. J. Dougherty, “Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy”, Cancer Res., 45:572–576 (1985)Google Scholar
  21. 21.
    F. A. H. Al-Watban, “Dosimetric parameter relationship of PDT in RIF-1: Clonogenic survival rate as a function of tumor volume”, Laser Med. Sci. Abstr. issue, Proceedings of the International Conference on PDT and Medical Laser Applications, London, p. 166. (1988).Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • F. A. H. Al-Watban
    • 1
  1. 1.Biomedical Physics Dept.King Faisal Specialist Hospital and Research CentreRiyadhSaudi Arabia

Personalised recommendations